SBIR Phase I: Enhancing the Efficacy of a Novel Cancer Drug through Combinatorial Chemistry

[04:19 . 42]这个小企业创新研究第一阶段项目提出通过组合化学方法，以一种新的先导分子为基础，提高一种新的抗癌药物的疗效。初步数据显示，在高剂量的情况下，这种药物能够杀死癌细胞，同时不影响非癌细胞。该项目的商业应用将在乳腺癌的抗癌治疗领域。

0419421StevensonThis Small Business Innovation Research Phase I project proposes to enhance the efficacy of a new anti-cancer drug, based on a novel lead molecule, through combinatorial chemistry. Preliminary data have shown that this drug, in higher doses, has the ability to kill cancerous cells while leaving non-cancerous cells unaffected.The commercial application of this project will be in the area of anti-cancer therapeutics for treatment of breast cancer.